biolitec, Inc. is currently seeking investigators and subjects for a new clinical study to assess the efficacy of laser light at the 980nm wavelength in healing all diabetic foot wounds. The selection process for qualified investigators is underway with the objective of establishing several study sites in the United States.
       The study entails the application of laser light at the 980nm wavelength using the biolitec Ceralas D diode laser and a special collimating handpiece to subjects' wounds over the course of several weeks or until complete healing is achieved.
       biolitec will provide individual investigators with funds for the recruitment of study subjects. In addition, biolitec is also offering other incentives to assist skilled, progressive podiatrists with the study and in the procurement of the Ceralas D laser.
       Investigator responsibilities include IRB and FDA approval prior to subject participation; receipt of subject informed consent; reporting of adverse reactions; accurate record keeping; and conducting the investigation in accordance with the investigational plan and FDA regulations.
       To obtain an Investigator Application or for more information about previous wound healing studies completed by the Ohio College of Podiatric Medicine, please contact biolitec by phone at (800) 934-2377 or via e-mail at woundhealstudy@biolitec.com.